Pilocarpine Hydrochloride
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01085 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 35 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | primary hereditary glaucoma | KG + DL |
| 2 | oral candidiasis | KG + DL |
| 3 | glaucoma 1, open angle | KG + DL |
| 4 | open angle glaucoma | KG + DL |
| 5 | osteoradionecrosis of the mandible | KG + DL |
| 6 | commissural lip fistula | KG + DL |
| 7 | burning mouth syndrome | KG + DL |
| 8 | oral leukoedema | KG + DL |
| 9 | chronic tic disorder | KG + DL |
| 10 | benign shuddering attacks | KG + DL |
| 11 | extrapyramidal and movement disease | KG + DL |
| 12 | lingual-facial-buccal dyskinesia | KG + DL |
| 13 | Axenfeld anomaly | KG + DL |
| 14 | psychogenic movement disorders | KG + DL |
| 15 | benign paroxysmal tonic upgaze of childhood with ataxia | KG + DL |
| 16 | primary orthostatic tremor | KG + DL |
| 17 | tremor-nystagmus-duodenal ulcer syndrome | KG + DL |
| 18 | glaucoma | KG + DL |
| 19 | fibroma of prostate | KG + DL |
| 20 | benign reproductive system neoplasm | KG + DL |
| 21 | benign prostate phyllodes tumor | KG + DL |
| 22 | Brenner tumor | KG + DL |
| 23 | male reproductive organ cancer | KG + DL |
| 24 | androgen insensitivity syndrome | KG + DL |
| 25 | primitive portal vein thrombosis | KG + DL |
| 26 | idiopathic copper-associated cirrhosis | KG + DL |
| 27 | early-onset familial noncirrhotic portal hypertension | KG + DL |
| 28 | hepatoportal sclerosis | KG + DL |
| 29 | hepatopulmonary syndrome | KG + DL |
| 30 | salivary gland disease | KG + DL |
| 31 | candidiasis | KG + DL |
| 32 | acute pulmonary heart disease | KG + DL |
| 33 | prostate leiomyoma | KG + DL |
| 34 | hepatic porphyria | KG + DL |
| 35 | prostate cancer/brain cancer susceptibility | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.